ORIC – oric pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $20.00 price target on the stock.
ORIC® Pharmaceuticals Reports Third Quarter 2024 Financial Results and Operational Updates
ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences
ORIC Pharmaceuticals, Inc. (NASDAQ: ORIC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $21.00 price target on the stock.
ORIC® Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Form SC 13G/A Oric Pharmaceuticals, Filed by: EcoR1 Capital, LLC
Form SC 13G/A Oric Pharmaceuticals, Filed by: Nextech Crossover I GP S.a r.l.
Form SC 13G/A Oric Pharmaceuticals, Filed by: COLUMN GROUP II, LP
Form SC 13G/A Oric Pharmaceuticals, Filed by: ALKEON CAPITAL MANAGEMENT LLC
Form 10-Q Oric Pharmaceuticals, For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.